Half of all FDA investigator site inspections find GCP non-compliance. Informed consent appears in the top three findings — every single year.
The sites that failed had complete training records. The problem was never knowledge. It was judgement. DOKIMA trains the judgement that prevents the finding.
Whether you are exploring a pilot, asking about licensing, or want to understand how DOKIMA fits your inspection readiness programme — reach out directly.
Sachin Pasumamula is the Founder and CEO of Sparsh Strategic Consulting Pte. Ltd. with 25+ years of GxP quality assurance expertise across Asia Pacific. He is also the author of Quiet Watchdogs: The Unsung Heroes of GxP and the inventor of SQIP — the world's first Causal Quality Intelligence Platform (patent filed, Singapore, April 2026).